Seiten sind aktuell sortiert nach: Datum (erst neue Artikel)
What are the Global Growth Factors? Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of global Cell Sorting Market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. What The Experts Says about the Market Growth? The cell sorting market is expe ...
The major factors driving the growth of are process and preparative chromatography market the increasing prevalence of appendicitis and growing preference for R&D investments in biotechnology and pharmaceutical companies. Increasing demand for insulin, vaccines, and monoclonal antibodies; rising number of chromatography conferences; and high demand for omega-3 fatty acids are the major driving factors for this market. Market Size The Preparative and Process Chromatography Market size is expected to reach USD 8.60 billion by 2023 from the estimated USD 6.27 billion in 2018, at a CAGR o ...
The growth in Specialty PACS Market is driven mainly by the increasing geriatric population and subsequent growth in the incidence of various diseases, advantages associated with specialty PACS, government initiatives to increase the adoption of healthcare IT solutions, growing investments in medical imaging, rising adoption of medical imaging IT solutions, and increasing use of imaging equipment. Market Size The specialty PACS market is projected to reach USD 3.5 billion in 2024 from USD 2.6 billion in 2019, at a CAGR of 6.0%. To know about the assumptions considered for the study download ...
What is the future growth analysis of global Oligonucleotide Synthesis Market? The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7% What are key factors driving growth of global Oligonucleotide Synthesis Market? This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques. What the growth opportunities are in Oligonucleotide Synthesis Market? 1. Untapped Emerging Market ...
According to the new market research report "Endoscope Reprocessing Market by Product (High-level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors, Endoscope Tracking Systems, Brushes), End User (Hospitals, Ambulatory Surgery Centers) - Global Forecast", published by MarketsandMarkets™. Factors such as high risk of infections associated with improper sterilization of endoscopes, increasing investments, funds, and grants by government bodies across the globe, rising number of hospitals and growing hospital investments in endoscopy instruments, ...
Der erste jährliche Pharmaceutical Invention Index, der heute von IDEA Pharma veröffentlicht wurde, setzt AstraZeneca an die Spitze der Branche für die Neuheiten und den Umfang seiner Pipeline für pharmazeutische Erfindungen. Der 2019 erstmals auf dem Pharma Innovation Summit in Boca Raton, FL, USA, veröffentlichte Pharmaceutical Invention Index wirft einen fokussierten Blick auf die Breite und Tiefe neuartiger Wirkstoffe, die derzeit innerhalb der innovativsten Pharma-Pipelines entwickelt werden. Neben dem Pharmaceutical Innovation Index, der Unternehmen nach ihrer Fähigkeit bewert ...
The live cell imaging market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9%. Growth in Live Cell Imaging market the can primarily be attributed to various factors such as the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research. The global live cell imaging market is segmented into instruments, consumables, software, and services. In 2018, the instruments segment accounted for the largest share of the live cell imaging market. Factors such as the l ...
According to the new market research report "Surface Disinfectants Market by Type (Quaternary Ammonium Compounds, Chlorhexidine Gluconate, Phenol, Alcohol, Aldehyde), Formulation (Liquid, Spray, Wipe), Application (In-house, Instrument), End User (Hospitals, Laboratories) - Global Forecast”, published by MarketsandMarkets™, The increasing number of surgical procedures, rising geriatric population, and subsequent growth in the prevalence of chronic diseases are major factors that are driving the growth of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadN ...
According to a new market research report "3D Cell Culture Market by Product (Scaffold-free (Hanging Drop, Bioreactor), Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell Research, Drug Discovery), End User (Pharmaceutical, Biotech, Research) - Global Forecast to 2022", published by MarketsandMarkets™, the 3D Cell Culture Market is expected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. The growth of the market is attributed to the rising focus on developing alternative methods for animal testing, funding initiatives from gov ...
Invivoscribe Inc. gab heute bekannt, dass die Europäische Kommission (EK) eine Zulassung für das Astellas-Medikament XOSPATA(TM) (Gilteritinib) erteilt hat. Dabei handelt es sich um eine Monotherapie für die Behandlung von erwachsenen Patienten, die unter einer rezidivierten oder refraktären, akuten myeloischen Leukämie (AML) mit FLT3-Mutationen (FLT3mut+) leiden, welche vom LeukoStrat® CDx FLT3-Mutations-Assay von Invivoscribe entdeckt werden können. Der LeukoStrat-Test ist als Test-Menü-Service über die Tochtergesellschaften von Invivoscribe LabPMM LLC (San Diego, Kalifornien, U ...
Ressourcenschonende Lösungen aus Kunststoff ? unter diesem Motto steht der Auftritt der Pöppelmann Gruppe aus Lohne. Mit der unternehmensweiten Initiative PÖPPELMANN blue®setzt sich die Gruppe für den schonenden Umgang mit Ressourcen ein und strebt, wo möglich, mit innovativen Produkten einen geschlossenen Materialkreislauf an. Reduce, reuse, recycle ? Kunststoff sorgsam einsetzen Kunststoff ist in die Kritik geraten. Dabei wird häufig vergessen, dass es sich dabei um ein wertvolles, vielseitig einsetzbares Material handelt, das Grundlage vieler zukunftsweisender Technologien ist. Die Pöppelma ...
The high incidence of allergic diseases is one of the major factors driving the growth of this market. The rising environmental pollution levels and the growing need for relatively faster, accurate, and high-throughput technologies for allergy diagnostics are the major factors supporting the growth of this market. According to the new market research report "Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecas ...
CEM Corporation hat heute den Abschluss einer endgültigen Vereinbarung zur Übernahme der Laborgerätesparte der Intavis Bioanalytical Instruments AG mit Sitz in Köln (Deutschland) bekanntgegeben. Mit der Übernahme stärkt CEM sein Produktportfolio im Life Sciences-Bereich für Proteomik, In-situ-Hybridisierung und insbesondere auf dem Gebiet der Peptidsynthese. Die Laborgeräte von Intavis weisen eine einzigartige robotergesteuerte Synthesetechnologie auf, die sich perfekt mit den Mikrowellen-Peptid-Synthesizern von CEM ergänzt. Speziell geht es um hochgradig parallele Formate im klei ...
Wie heute gemeldet wurde, wird Chugai Pharmaceutical Co., Ltd. ("Chugai"), ein Mitglied der Roche Group, die Zugriffslizenz des Unternehmens für das Immunogenicity Screening and Protein Reengineering Interface (ISPRI) Toolkit verlängern, das von EpiVax, Inc. ("EpiVax") entwickelt wurde. Chugai, ein führendes japanisches forschungsorientiertes Pharmaunternehmen, dessen Stärken im Bereich der Biotechnologieprodukte liegen, integrierte das fortschrittliche ISPRI-Toolkit nach einem umfassenden Direktvergleich mit anderen in-silico-Toolkits im September 2013 in seine ...
Der Europäische Gerichtshof hat mangels eines europäischen Rechtsrahmens einen Gerichtsbeschluss veröffentlicht, der es Lebensmittelherstellern erlaubt, im Kampf gegen Listerien auf Lebensmitteln weiter Bakteriophagen einzusetzen. Werden Phagen, die speziell Listerien abtöten, bei der Herstellung von Lebensmitteln eingesetzt, können sie verhindern, dass sich die tödlichen Keime ausbreiten. Eine vorsorgliche Maßnahme, die Leben retten kann: Listerien-Ausbrüche in Spanien, Deutschland, Österreich, der Schweiz und den Niederlanden haben in den letzten Monaten zu Hunderten Erkrankungen ...
The growth of this market is primarily driven by the increasing incidence of target diseases and the subsequent growth in the number of surgical procedures, growing demand for minimally invasive surgeries, and technological advancements. However, the high cost of devices and the extensive clinical data requirements for launching new products are expected to restrain the growth of this market during the forecast period. Market Size - The global anastomosis devices market is projected to reach USD 2.9 billion by 2024 from an estimated USD 2.1 billion in 2019 at a CAGR of 7.2%. The anastomosi ...
The Market Research Report on Biobanking, Considering useful aspects like; Application, Sample Type — Global Future Forecast, published by MarketsandMarkets™. Factors driving the growth of this Biobanking Market include the increasing number of genomics research activities for studying diseases; advances in biobanking and the growing trend of conserving cord blood stem cells of newborns; government & private funding to support regenerative medicine research; and the growing need for cost-effective drug discovery and development. The equipment segment is estimated to a ...
Während einer der führenden Lebensmittel- und Gesundheitsmessen in den USA, der Supply Side West (SSW) Expo, unterzeichneten Vertreter von GELITA und Geltor eine Absichtserklärung zur Entwicklung, Herstellung und Vermarktung der ersten verzehrbaren biotechnologisch hergestellten Kollagenproteine. Die kommerzielle Vermarktung ist für Ende 2020 geplant. Gemäß dieser Vereinbarung wird Geltor das Premium-Kollagen biotechnologisch entwickeln und herstellen, während GELITA die notwendigen klinischen Studien zur Wirksamkeit durchführt und danach die Vermarktung in Ergänzung zu dem existier ...
The ELISpot and FluoroSpot Assay market is projected to reach USD 287 million by 2023 from USD 135 million in 2018, at a CAGR of 16.2% during the forecast period. Growth in this market is driven by the rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers. The ELISpot and FluoroSpot market is segmented into assay kits, analyzers, and ancillary products. The assay kits are further subsegmented by utility, type, and analyte. In 2018, th ...
The Hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.14 billion in 2017 at a CAGR of 6.0%. Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries. The hemostats market is segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. Of all these produc ...
